Marius Pharmaceuticals, LLC
RALEIGH, NC · Founded 2016 · CIK 0001777443 · Biotech · Private
Hormone-based pharmaceutical therapies for metabolic and endocrine conditions
mariuspharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $5.6M
- 2 Form D · Jun 2019
- 87 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 4 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,603,850 | |
| Private capital raised | Form D · SEC | $20,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1809 | ImmunityBio, Inc. | — | $633M |
| 1810 | MODERN MEADOW | — | $53M |
| 1811 | Sapience Therapeutics Inc. | — | $8.3M |
| 1812 | Marius Pharmaceuticals, LLC | — | $5.6M |
| 1813 | MDI Therapeutics Investors, LLC | — | — |
| 1814 | Rectify | — | — |
| 1815 | Phylo | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Om DhingraDirector · Executive Officer
- Amit ShahDirector
- Himanshu ShahDirector · Executive Officer
- Shalin ShahExecutive Officer
Patents
- Emulsion Formulationsgranted
- Modulation Of Solubility, Stability, Absorption, Metabolism, And Pharmacokinetic Profile Of Lipophilic Drugs By Sterolsgranted
- Modulation Of Solubility, Stability, Absorption, Metabolism, And Pharmacokinetic Profile Of Lipophilic Drugs By Sterolsgranted
- Modulation Of Solubility, Stability, Absorption, Metabolism, And Pharmacokinetic Profile Of Lipophilic Drugs By Sterolsgranted
- Emulsion Formulationsapplication
- Emulsion Formulationsapplication
- Preferred Oral Testosterone Undecanoate Therapy To Achieve Testosterone Replacement Treatmentapplication
- Preferred Oral Testosterone Undecanoate Therapy To Achieve Testosterone Replacement Treatmentapplication
- Preferred Oral Testosterone Undecanoate Therapy To Achieve Testosterone Replacement Treatmentapplication
- Emulsion Formulationsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.